Zevra Therapeutics Inc. (ZVRA) support and resistance · P/E 6.3, rev $75.9M
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
This page maps Zevra Therapeutics Inc. (ZVRA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
ZVRA currently screens at market cap $745.4M and trailing P/E 6.3. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ZVRA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ZVRA quote page for the session range and the stock page for the full model.
Not investment advice.